Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

This study has been completed.
Oxford Immunotec
Information provided by:
University Health Network, Toronto Identifier:
First received: August 22, 2005
Last updated: December 22, 2010
Last verified: July 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)